Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
Revenues | 572.3 | 470.7 | 339.6 | 300.5 | |
Revenue growth | 21.6% | 38.6% | 13.0% | | |
Cost of goods sold | 110.2 | 101.5 | 97.0 | 94.7 | |
Gross profit | 462.2 | 369.2 | 242.6 | 205.9 | |
Gross margin | 80.8% | 78.4% | 71.4% | 68.5% | |
Sales and marketing | 164.6 | 114.3 | 76.8 | 61.0 | |
Research and development | 115.0 | 80.8 | 52.3 | 34.8 | |
General and administrative | 103.6 | 73.6 | 54.4 | 50.0 | |
EBITA | -10.3 | -19.3 | -7.5 | 8.0 | |
EBITA margin | -1.8% | -4.1% | -2.2% | 2.7% | |
Amortization of intangibles | 12.0 | 10.8 | 9.6 | 4.3 | |
EBIT | -22.2 | -30.2 | -17.2 | 3.7 | |
EBIT margin | -3.9% | -6.4% | -5.1% | 1.2% | |
Pre-tax income | 1.6 | -25.2 | -15.3 | 4.2 | |
Income taxes | 13.6 | 8.7 | 8.3 | 4.7 | |
Tax rate | 839.7% | | | 113.1% | |
Net income | -12.0 | -34.0 | -23.7 | -0.6 | |
Net margin | -2.1% | -7.2% | -7.0% | -0.2% | |
|
Diluted EPS | ($0.03) | ($0.17) | ($0.51) | ($0.02) | |
Shares outstanding (diluted) | 348.0 | 202.9 | 47.0 | 36.1 | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|